Company Announcements

DeepVerge presents at Global Group Investor Summit

Source: RNS
RNS Number : 2504J
Deepverge PLC
26 April 2022


26 April 2022

DeepVerge PLC


("DeepVerge" or "the Company")


DeepVerge to Present at the Global Group UK Investor Summit


DeepVerge (LSE:DVRG.L) is delighted to announce that the Company will be exhibiting and presenting live at the Global Group UK Investor Summit on May 21st 2022 at QEII Centre, Westminster, London.


DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins; Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and remotely detecting and identifying in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs. 


Our divisions include:
Life Science: Labskin, Skin Trust Club 

Environmental Health: Modern Water



Labskin is a world leading platform that has been producing lab grown human skin for 15 years and using it to test cosmetic and skin health products for some of the world's leading brands. Labskin is a 3D human skin equivalent that incorporates vital biological components to model normal skin function. It provides a viable in-vitro alternative to animal testing and ending needless animal testing is at the core of the Labskin mission.


Skin Trust Club

Skin Trust Club, powered by Labskin, is a skin health tracking app that provides personalised skincare suggestions based on an individual's unique skin microbiome. Our Home Test Kit comprises a single swab that maps the skin microbiome delivering a report that produces the most appropriate daily skincare routine based on science. Using real-time air pollution and weather data from the customer's location, the Skin Trust App builds a complete picture of the skin microbiome and the impact of local surroundings.


Modern Water 

Modern Water is the gold standard in water testing across 60+ countries. A pioneering and innovative technology company, specialising in advanced monitoring products, Modern Water has developed technologies which can detect pathogens in wastewater in real time. The information is then fed into a computer and artificial intelligence is used to predict where public health bodies should target their resources to contain any potential outbreaks.


Gerry Brandon, CEO of DeepVerge, will present an overview of the business and investment opportunities. We are exhibiting at stand 29, so please drop by to meet the team and discuss any business angles.


For further information please contact:

DeepVerge plc

Gerard Brandon, CEO

+44 (0) 7340 055 648

SPARK Advisory Partners (Nominated Adviser)

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/James Pope

+44 (0) 20 3657 0050


About Reach announcements

Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.


This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.